Emilie K. Mitten

553 citations
10 papers · 403 indexed · h-index 7
Topics
Liver Disease and Transplantation (2 papers)Hippo pathway signaling and YAP/TAZ (2 papers)Liver Disease Diagnosis and Treatment (2 papers)

In The Last Decade

Emilie K. Mitten

9 papers receiving 397 citations

Peers

Emilie K. Mitten
Comparison fields: 5 of 68
  • Molecular Biology 190
  • Endocrinology, Diabetes and Metabolism 151
  • Epidemiology 104
  • Surgery 62
  • Physiology 56
Replace Lu Lin with:
Lu Lin China
Valentina Ceccarelli Italy
Ke He China
Konstantinos Stefanakis United States
Laura Valenzuela‐Vallejo United States
Clare Jones United States
C. Beglinger Switzerland
Darline Garibay United States
Anna Stępień Poland
Sandra Handgraaf Switzerland
Emilie K. Mitten relative to Lu Lin China Lu Lin's profile →
Citations per field
00.5×10×15.5×
Lu Lin · 1×
Citations per year

Countries citing papers authored by Emilie K. Mitten

Since Specialization
Citations

This map shows the geographic impact of Emilie K. Mitten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilie K. Mitten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilie K. Mitten more than expected).

Fields of papers citing papers by Emilie K. Mitten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilie K. Mitten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilie K. Mitten. The network helps show where Emilie K. Mitten may publish in the future.

Co-authorship network of co-authors of Emilie K. Mitten

This figure shows the co-authorship network connecting the top 25 collaborators of Emilie K. Mitten. A scholar is included among the top collaborators of Emilie K. Mitten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilie K. Mitten. Emilie K. Mitten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 4
2 8
3 10
4 0
5 43
6 2
7 13
8 186
9 26
10 111

About Emilie K. Mitten

Emilie K. Mitten is a scholar working on Hepatology, Cell Biology and Gastroenterology, having authored 10 papers that have together received 403 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (151 citations), Hepatology (31 citations) and Endocrine and Autonomic Systems (24 citations). Emilie K. Mitten has collaborated with scholars based in United States, Italy and Austria. Frequent co-authors include Jody Dushay, Eleftheria Maratos–Flier, Elena Toschi, Mark A. Herman, Ffolliott M. Fisher, György Baffy, Elissa H. Wilker, Chong Gao, Meghan B. Crawley and Gosala Gopalakrishnan. Their work appears in journals such as Diabetes Care, The Journal of Infectious Diseases and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026